182 related articles for article (PubMed ID: 3121752)
1. Microplate immunocapture assay for plasminogen activators and their specific inhibitors.
Stephens R; Leung KC; Pöllänen J; Salonen EM; Vaheri A
J Immunol Methods; 1987 Dec; 105(2):245-51. PubMed ID: 3121752
[TBL] [Abstract][Full Text] [Related]
2. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
Wijngaards G
Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
[TBL] [Abstract][Full Text] [Related]
3. Purification of epidermal plasminogen activator inhibitor.
Hibino T; Izaki S; Izaki M
FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator and its inhibitor PAI-1 in breast cancer: studies at both protein and mRNA level.
Reilly D; Andreasen P; Duffy MJ
Biochem Soc Trans; 1991 Feb; 19(1):44S. PubMed ID: 1903741
[No Abstract] [Full Text] [Related]
5. Plasminogen activator system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies.
Nielsen LS; Grøndahl-Hansen J; Andreasen PA; Skriver L; Zeuthen J; Danø K
J Immunoassay; 1986; 7(3):209-28. PubMed ID: 3091639
[TBL] [Abstract][Full Text] [Related]
7. Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin).
Leung KC; Byatt JA; Stephens RW
Thromb Res; 1987 Jun; 46(6):767-77. PubMed ID: 3114909
[TBL] [Abstract][Full Text] [Related]
8. Amiloride selectively inhibits the urokinase-type plasminogen activator.
Vassalli JD; Belin D
FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
[TBL] [Abstract][Full Text] [Related]
9. Imbalance between plasminogen activator and its inhibitors in thiol-induced acantholysis.
Lombardi ML; de Angelis E; Rossano F; Ruocco V
Dermatology; 1993; 186(2):118-22. PubMed ID: 8428039
[TBL] [Abstract][Full Text] [Related]
10. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
Karlan BY; Clark AS; Littlefield BA
Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators in synovial fluid and plasma from patients with arthritis.
Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
Ann Rheum Dis; 1992 Aug; 51(8):965-8. PubMed ID: 1417121
[TBL] [Abstract][Full Text] [Related]
12. A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.
Reboud-Ravaux M; Vilain AC; Boggetto N; Maillard J; Favreau C; Xie J; Mazaleyrat JP; Wakselman M
Biochem Biophys Res Commun; 1991 Jul; 178(1):352-9. PubMed ID: 1829886
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of plasminogen activators and the growth of cultured human tumour cells.
Scott GK
Int J Biochem; 1988; 20(8):817-22. PubMed ID: 3139480
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
Brown JM; Watanabe K; Cohen RL; Chambers DA
Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
Grøndahl-Hansen J; Ralfkiaer E; Nielsen LS; Kristensen P; Frentz G; Danø K
J Invest Dermatol; 1987 Jan; 88(1):28-32. PubMed ID: 3098860
[TBL] [Abstract][Full Text] [Related]
17. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
[TBL] [Abstract][Full Text] [Related]
18. Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation.
Stephens RW; Fordham CJ; Doe WF
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):213-22. PubMed ID: 2965017
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
Félez J; Rueda F
Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
[No Abstract] [Full Text] [Related]
20. Properties of a partially purified preparation of a circulating plasminogen activator.
Ogston D; Bennett B; Mackie M
Thromb Res; 1976 Mar; 8(3):275-84. PubMed ID: 131386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
